Revolution Medicines (RVMD) Shares Outstanding (2018 - 2026)

Revolution Medicines has reported Shares Outstanding for 9 years, with the latest figure at $200.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 7.47% year-over-year to $200.2 million; the trailing twelve-month figure through Mar 2026 stood at $200.2 million (up 7.47% YoY), and the FY2025 full-year result was $197.0 million, up 5.97% from the prior year.
• Shares Outstanding for Q1 2026 stood at $200.2 million, up from $197.0 million in the prior quarter.
• The five-year high for Shares Outstanding was $200.2 million in Q1 2026, with the low at $2.0 million in Q1 2023.
• Average Shares Outstanding over 5 years is $138.6 million, with a median of $164.9 million recorded in 2024.
• Year-over-year, Shares Outstanding advanced 1.08% in 2022 and surged 82.14% in 2023.
• Tracing RVMD's Shares Outstanding over 5 years: stood at $90.4 million in 2022, then surged by 82.14% to $164.7 million in 2023, then advanced by 12.89% to $185.9 million in 2024, then climbed by 5.97% to $197.0 million in 2025, then climbed by 1.61% to $200.2 million in 2026.
• The last three Shares Outstanding figures came in at $200.2 million (Q1 2026), $197.0 million (Q4 2025), and $189.7 million (Q3 2025), per Business Quant data.

Peer Comparison